Robert I. Kelly

Fitzroy, VIC, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 36 publications

Clinicopathological features of lymphocytic thrombophilic arteritis and the relationship with livedoid vasculopathy - a case series of 36 patients.

Clinicopathological features of lymphocytic thrombophilic arteritis and the relationship with livedoid vasculopathy - a case series of 36 patients.

Journal: The British journal of dermatology

Published: March 30, 2026

Initial development and pragmatic clinical validation of a static disease severity instrument for pyoderma gangrenosum: Investigator Global Assessment for PG (IGAPg).

Initial development and pragmatic clinical validation of a static disease severity instrument for pyoderma gangrenosum: Investigator Global Assessment for PG (IGAPg).

Journal: medRxiv : the preprint server for health sciences

Published: January 29, 2026

Pyoderma Gangrenosum: Association of Ulcer Size With Clinical Characteristics and Healing Outcomes.

Pyoderma Gangrenosum: Association of Ulcer Size With Clinical Characteristics and Healing Outcomes.

Journal: The Australasian journal of dermatology

Published: January 01, 2026

Initial development and pragmatic clinical validation of a static disease severity instrument for pyoderma gangrenosum: Investigator Global Assessment for PG (IGAPg).

Initial development and pragmatic clinical validation of a static disease severity instrument for pyoderma gangrenosum: Investigator Global Assessment for PG (IGAPg).

Journal: Journal of the American Academy of Dermatology

Published: September 03, 2025

Minimum dataset for treatment effectiveness in pyoderma gangrenosum for an international registry: an international multidisciplinary eDelphi consensus.

Minimum dataset for treatment effectiveness in pyoderma gangrenosum for an international registry: an international multidisciplinary eDelphi consensus.

Journal: The British journal of dermatology

Published: August 13, 2025

The role of innovative financing to bridge the gap between implementation and commercialisation.

The role of innovative financing to bridge the gap between implementation and commercialisation.

Journal: Malaria journal

Published: April 14, 2025

Pyoderma gangrenosum refined elements for core item selection and evaluation (PRECISE-PG): a study protocol for reaching consensus on core outcome domain items in clinical trials of pyoderma gangrenosum.

Pyoderma gangrenosum refined elements for core item selection and evaluation (PRECISE-PG): a study protocol for reaching consensus on core outcome domain items in clinical trials of pyoderma gangrenosum.

Journal: Archives of dermatological research

Published: November 25, 2024

Living with Pyoderma Gangrenosum: A Qualitative Study.

Living with Pyoderma Gangrenosum: A Qualitative Study.

Journal: Acta dermato-venereologica

Published: September 16, 2024

The efficacy of intravenous immunoglobulin for the treatment of pyoderma gangrenosum: A systematic review and meta-analysis.

The efficacy of intravenous immunoglobulin for the treatment of pyoderma gangrenosum: A systematic review and meta-analysis.

Journal: Journal of the European Academy of Dermatology and Venereology : JEADV

Published: July 09, 2024

A case of concomitant clinical and histopathologic features of lymphocytic thrombophilic arteritis and livedoid vasculopathy.

A case of concomitant clinical and histopathologic features of lymphocytic thrombophilic arteritis and livedoid vasculopathy.

Journal: JAAD case reports

Published: October 16, 2023

Minimum data set for treatment effectiveness in pyoderma gangrenosum (MIDSTEP): an international protocol of an e-Delphi study to develop a clinical physician-driven treatment effectiveness registry on behalf of the UPGRADE initiative.

Minimum data set for treatment effectiveness in pyoderma gangrenosum (MIDSTEP): an international protocol of an e-Delphi study to develop a clinical physician-driven treatment effectiveness registry on behalf of the UPGRADE initiative.

Journal: Archives of dermatological research

Published: August 02, 2023

Treatment of severe, refractory pyoderma gangrenosum with infliximab, adalimumab and intravenous immunoglobulin.

Treatment of severe, refractory pyoderma gangrenosum with infliximab, adalimumab and intravenous immunoglobulin.

Journal: The Australasian journal of dermatology

Published: January 17, 2023

Showing 1-12 of 36

Last Updated: 09/26/2026